Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 4, Issue 3, 2005, Pages 209-

  Spencer, Helen ^a   Kozlowska, Wanda ^a   Davies, Jane C ^a   Webber, Peter ^a   Chadwick, Maureen ^a   Kerr, Jonathan ^a   Makhecha, Sukeshi ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; TOBRAMYCIN;

ADOLESCENT; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG IDENTIFICATION; DRUG MONITORING; DRUG SALIVA LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; LETTER; LUNG INFECTION; PRESCRIPTION; SALIVA ANALYSIS; SIDE EFFECT; TIME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DRUG MONITORING; GENTAMICINS; HUMANS; IMMUNOASSAY; SALIVA; TOBRAMYCIN;

EID: 23944517983     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.05.016     Document Type: Letter

References (3)

1. V. Madsen A. Lind M. Rasmussen K. Coulthard Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis J Cyst Fibros 3 2004 249-251
2. M. Berkovitch T. Bistritzer M. Aladjem P. Burtin T. Dagan Z. Chen-Levi et al. Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children Ther Drug Monit 20 1998 253-256
3. M. Berkovitch M. Goldman R. Silverman Z. Chen-Levi R. Greenberg O. Marcus et al. Therapeutic drug monitoring of once daily gentamicin in serum and saliva of children Eur J Pediatr 159 2000 697-698